Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome

Launched by UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO · Mar 17, 2020

Keywords

ClinConnect Summary

The study will be carried out at the oral medicine clinic of the Division of Postgraduate Studies and Research of the Faculty of Dentistry of the National Autonomous University of Mexico, during the period of August 2019 to June 2020. This research was approved by the Ethics and Research Committee of the Faculty of Dentistry - Universidad Nacional Autonoma de Mexico. Inclusion criteria will be all patients with BMS, indistinctively of gender. The sample size will be 10 patients in each group, calculated using PaaS computer program with a power of 90.552% to reject the null hypothesis; based...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Burning mouth sensation without oral lesions that could be involved with painful symptoms
• • Symtoms of burning sensation more than 3 months
• Exclusion Criteria:
• • Patients who are under antineoplastic treatment or with a history of malignant neoplasms of the head and neck
• • Active treatment with benzodiazepines or systemic antidepressants
• • Pregnant women
• • Patients unable to follow the indications for administration of oral topical medications
• • Unstimulated saliva production ≤ 0,1 mililiters/minute
• • Sistemic diseases that can produce burning sensation